Childress Capital Advisors’s Medifast MED Stock Holding History

Childress Capital Advisors’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10	Closed	-$2K	–	625
2020 Q4	$2K	Buy	+10	New	+$1.77K	﹤0.01%	974

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Childress Capital Advisors's MED Position: Q1 2021 in Review

Childress Capital Advisors sold out of Medifast (MED) in Q1 2021, closing a stake of 10 shares — an estimated $2K sold.

Childress Capital Advisors first reported a position in MED in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 277 funds tracked by Wall St. Rank hold MED as of Q1 2021.

Childress Capital Advisors reported no remaining Medifast position as of Q1 2021 after selling out during the quarter.
Childress Capital Advisors sold 10 Medifast shares in Q1 2021, an estimated $2K.
Childress Capital Advisors first reported a position in Medifast in Q4 2020 and held it in 1 quarter.
Childress Capital Advisors's Medifast position peaked at $2K in Q4 2020.
277 funds tracked by Wall St. Rank held Medifast as of Q1 2021.

Based on Childress Capital Advisors's 13F filing for Q1 2021, filed 21 May 2021.